Repurposing therapy of ibrexafungerp vulvovaginal candidiasis drugs as cancer therapeutics.

Rustandi T, Yumassik AM, Ilahi FS, Alfian R, Prihandiwati E, Susanto Y, Susilo YH, Ulfah M, Faizatun F

DOI: 10.3389/fphar.2024.1428755
Published: 2024
Container: Frontiers in pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2024.1428755,
  title = {Repurposing therapy of ibrexafungerp vulvovaginal candidiasis drugs as cancer therapeutics.},
  author = {Rustandi T and Yumassik AM and Ilahi FS and Alfian R and Prihandiwati E and Susanto Y and Susilo YH and Ulfah M and Faizatun F},
  year = {2024},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2024.1428755},
  url = {https://doi.org/10.3389/fphar.2024.1428755}
}

RIS

TY  - JOUR
TI  - Repurposing therapy of ibrexafungerp vulvovaginal candidiasis drugs as cancer therapeutics.
AU  - Rustandi T
AU  - Yumassik AM
AU  - Ilahi FS
AU  - Alfian R
AU  - Prihandiwati E
AU  - Susanto Y
AU  - Susilo YH
AU  - Ulfah M
AU  - Faizatun F
PY  - 2024
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2024.1428755
UR  - https://doi.org/10.3389/fphar.2024.1428755
ER  -

APA

T, R., AM, Y., FS, I., R, A., E, P., Y, S., YH, S., M, U., & F, F. (2024). Repurposing therapy of ibrexafungerp vulvovaginal candidiasis drugs as cancer therapeutics.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2024.1428755

Source records

pubmed · retrieved 2026-09-27T14:01:44.069Z